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Although several studies have dealt with the patterns of cytokine production in tuberculosis, little is known 
about the association between nutrient deficiencies and cytokines in tuberculosis. The objective of this study 
was to assess the concentration of cytokines related to nutritional status during tuberculosis.  In 41 untreated 
tuberculosis patients and matched healthy controls in an urban hospital in Indonesia, we measured: height and 
weight, parameters of iron, vitamin A and zinc; and cytokines concentrations in the circulation and production 
in whole blood cultures.  Plasma interleukin-6 (IL-6) and interleukin-1 receptor antagonist (IL-1ra) were sig-
nificantly higher in patients than in controls. Patients with cavities (n=26) had higher concentrations of IL-6 
than patients without cavities (n=15). Body mass index <18.5 kg/m2 was associated with high concentrations of 
tumor necrosis factor-α (TNF-α) and IL-6. Anaemia was associated with high concentrations of IL-6 and 
IL-1ra. Zinc deficiency was associated with high LPS-stimulated production of TNF-α and IL-1ra. Marginal 
plasma retinol concentrations were associated with high concentrations of IL-6 after LPS stimulation. In con-
clusion, low concentrations of micronutrients in tuberculosis were associated with increased cytokine produc-
tion. An intervention study would allow causality to be examined. 
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Introduction   
Malnutrition is frequently observed during tuberculosis1, 
and is thought to influence host defence and thereby out-
come of the infection. How malnutrition affects host de-
fence is incompletely understood, but it may involve 
changes in the balance of pro- and antiinflammatory cyto-
kines. 
  Manifestations of tuberculosis such as fever, weight loss, 
prolonged acute-phase response and granuloma formation, 
are mediated by proinflammatory cytokines such as tumor 
necrosis factor (TNF), interleukin-1β (IL-1β) and inter-
leukin-6 (IL-6). Antiinflammatory cytokines such as IL-4, 
IL-10 and IL-1 receptor antagonist (IL-1ra) may also in-
fluence host defence against Mycobacterium tuberculosis. 
Deficiencies of micronutrients, as well as protein-energy 
malnutrition, diminish the non-specific host defence during 
infection2-4  including the production of cytokines.5,6 
Vitamin A deficiency induces a regulatory T-helper (Th) 
cell imbalance.7 Zinc deficiency decreases phagocytosis8 
and numbers of circulating T cells in animals9. Zinc defi-
ciency also leads to decreased production of IFN-γ, IL-1 
and TNF-α.6 Conversely, supplementation of micronutri-
ents such as vitamin A may increase production and/or 
release of IL-1β and TNF, and inhibit production of inter-
feron-γ (IFN-γ) and interleukin-2 (IL-2) in vitro.10-12 Zinc 
supplementation can regulate the production of IL-1α from 
alveolar macrophages in patients with pulmonary tubercu-
losis or bacterial pneumonia.13 In addition, vitamin A and 
zinc may improve the proliferation of T lymphocytes dur-
ing the response to tuberculin, Purified Protein Derivative 
(PPD).14  
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Although several studies have dealt with the patterns of 
cytokine production in tuberculosis, little is known about 
the association between nutrient deficiencies and cytokine 
production during active tuberculosis. The objective of 
this study was to assess concentrations of both circulating 
and ex-vivo produced cytokines, as well as the associa-
tion between nutritional status and cytokine production in 
tuberculosis patients and controls. Since cavitary tuber-
culosis is considered a more serious form of tuberculosis, 
in which necrosis prevails15, we also investigated whether 
cytokine patterns were different in patients with and 
without cavitary lesions.  
 
Materials and methods 
Patients  
The study was carried out as a case-control study at the 
Pulmonology Clinic of Cipto Mangunkusumo University 
Hospital associated with the Medical Faculty of the Uni-
versity of Indonesia in Central Jakarta, Indonesia. Sample 
size was calculated based on the ability to determine a 
difference with α=0.05 and 1-β=0.95 using one-tailed test 
for concentrations of cytokines, plasma retinol, zinc and 
of blood haemoglobin. It was calculated that with a sam-
ple size of 35 in each group, zinc concentrations as the 
parameter requiring the largest sample size could be de-
tected with between-group difference of 0.46 μmol/L.16 
Assuming that 25% of patients may not fulfil the inclu-
sion criteria, we recruited 45 subjects for each group. 
Newly diagnosed out-patients with pulmonary tuberculo-
sis were included as cases if they fulfilled all of the fol-
lowing 4 criteria: 1) age 15-55 yrs, 2) at least two sputum 
specimens positive for acid-fast bacilli by direct micros-
copy or one sputum specimen positive for culture, 3) ab-
normalities on chest X-ray, and 4) clinical examination 
consistent with pulmonary tuberculosis.17  
  Exclusion criteria were pregnancy, lactation, previous 
anti-tuberculosis medication, moderate to severe injury or 
surgery during the previous month, use of corticosteroids 
or supplements containing vitamin A, zinc, or iron during 
the previous month and presence of liver disease (ele-
vated serum levels of Aspartate Amino Transferase 
(ASAT) and Alanine Amino Transferase (ALAT)), dia-
betes mellitus (elevated fasting serum levels of blood 
glucose), neoplasm detected by clinical examination, 
chronic renal failure (elevated serum levels of urea or 
creatinine), or clinical signs of congestive heart failure.  
  Controls were selected from neighbours of the patients 
(non-family members) in the smallest administrative unit 
(‘rukun tetangga’) comprising about 20 houses, and were 
matched with cases for sex and age (within ± 2 yrs). For 
the selection of controls, a list of healthy subjects was 
requested from the head of the administrative unit (rukun 
tetangga) by the field workers and one control subject 
was selected randomly from the list of 3-7 persons. Con-
trols had no history of tuberculosis and no evidence of 
disease by clinical examination and laboratory assessment 
(total white blood cell count, and concentrations of 
C-reactive protein and fasting blood glucose). Informed 
consent was obtained from all subjects. The study was 
approved by the Committee on Health Research Ethics, 
Faculty of Medicine, University of Indonesia, Jakarta. 
 
Clinical examination  
Patients and controls were screened by using a structured 
questionnaire to collect information related to inclusion 
and exclusion criteria. Patients who were eligible were 
examined both clinically including Karnofsky score and 
body temperature, and by chest X-ray by one of authors 
(ZA) who is a pulmonologist at the Cipto Mangunkusumo 
University Hospital. 
 
Sputum examination  
Three specimens of early morning sputum from patients 
with suspected tuberculosis were examined for acid-fast 
bacilli by direct microscopy after Kinyoun Gabett stain-
ing (a modification of the Ziehl-Nielsen method)18, and 
one sputum was cultured in Kudoh medium.18 
 
Tuberculin skin test (Mantoux test) 
Skin test responses were stimulated by injecting PPD 0.1 
mL, 5 tuberculin units (TU) (Perum Biofarma, Pasteur 
Institute, Bandung, Indonesia) into the skin of the volar 
area of the forearm. Responses were assessed during 
48-72 h after injection by measuring the mean diameter of 
induration to the nearest mm, while induration ≥10 mm 
was considered as positive.  
 
Anthropometric measurements 
Subjects were weighed without shoes using an electronic 
platform model weighing scale (770 alpha; SECA, Ham-
burg, Germany). The weight was recorded to the nearest 
0.1 kg. Height was recorded to the nearest 0.1 cm using a 
microtoise. Body mass index (BMI) was calculated as 
body weight divided by height squared (kg/m2). Subjects 
with BMI <18.5 kg/m2 were regarded as malnourished.19 
 
Blood sampling 
Fasting blood samples (15 mL) were collected via 
venipuncture to determine haematocrit,  white blood 
cells count, erythrocyte sedimentation rate, and concen-
trations of haemoglobin in blood, zinc-protoporphyrin in 
washed erythrocytes, and  C-reactive protein, albumin, 
retinol, zinc and α-tocopherol in plasma. The blood was 
centrifuged at 750xg for 10 min at room temperature and 
the plasma collected and stored at -80°C until analysed. 
Determination of zinc-protoporphyrin, haemoglobin, 
haematocrit, white blood cells count, and albumin was 
carried out on the day of sampling.  
 
Biochemical tests 
Haemoglobin, haematocrit, white blood cell counts, 
ASAT and ALAT were measured directly using an auto-
matic analyzer (Sysmex Microdilutor F-800, Kobe, Ja-
pan). The cut-off points for normal haemoglobin were 
>120 g/L and >130 g/L and for haematocrit >0.37 and 
>0.40, for females and males respectively. The normal 
value for white blood cells was 5,000-10,000 cells/mm3. 
Erythrocyte sedimentation rate was determined according 
to Westergreen20 with normal values <20 mm/h. Albumin 
was determined by the bromcresol green method21 with 
normal values of 35-50 g/L. C-reactive protein was 
measured using an immunoturbidimetric assay22 
(Behringwerke, Marburg, West Germany) with normal 
values <5 mg/L. Zinc-protoporphyrin as a measure of free  
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erythrocyte protoporphyrin was estimated using the port-
able front-face hematofluorometer (AVIV Biomedical Co, 
Lakewood, NJ 08701). To determine the influence of 
components in plasma, we measured zinc-protoporphyrin 
in washed erythrocytes. For the washing procedure, we 
centrifuged the blood for 4 min at 1000xg just before the 
measurement, then removed the plasma and replaced it 
with isotonic saline to restore the original volume. After 
repeating the washing procedure, zinc-protoporphyrin 
was measured in 20 μL of the washed erythrocyte sus-
pension.23 Values <40 μmol/mol heme were regarded as 
normal. Plasma retinol concentration was measured by 
HPLC (Bondapak C-18 column,Waters, Milford, MA; 
model 6PD-6AV, Shimadzu, Tokyo; standards from 
Sigma, St Louis, MO) with methanol:water (95:5, vol:vol) 
as described previously and values <0.70 μmol/L were 
regarded as indicating marginally low vitamin A status.24 
Plasma zinc was measured by atomic absorption spec-
trometry with values <10.7 μmol/L regarded as zinc defi-
ciency.25 
 
Cytokine measurement 
For measurement of circulating cytokines, venous blood 
was sampled in sterile 4-mL EDTA tubes, and plate-
let-poor plasma was obtained by centrifugation. Ex-vivo 
production of cytokines was performed as previously de-
scribed.26 Briefly, for unstimulated cytokine production, a 
4-mL EDTA tube was incubated for 24 h at 37oC. For 
LPS-stimulated production, a similar tube was incubated 
with LPS (Escherichia coli serotype 055:b5; Sigma, St. 
Louis, final concentration 10 mg/L). After incubation for 
24 h, both LPS-stimulated and unstimulated samples were 
centrifuged and handled thereafter like the first tube. 
IL-1β, TNF-α, and IL-1ra were measured in duplicate by 
nonequilibrium RIA26. Recombinant human IL-1β, 
TNF-α, and IL-1ra were calibrated against standards pro-
vided by the National Institute of Biological Standards 
and Control (Potters Bar, UK) with the sensitivity of the 
assay with 100 μL sample of 40 pg/mL, 40 pg/mL, and 
80 pg/mL, respectively. IL-6 was measured with an 
ELISA (CLB, Amsterdam, The Netherlands).27 The de-
tection limit was 4 pg/mL. 
 
Statistical analysis 
One sample Kolmogorov-Smirnov test was used to check 
whether the variables were normally distributed. Data are 
expressed as mean ± standard deviation (SD) for nor-
mally distributed parameters while median and 25th–75th 
percentiles are used for non-normally distributed parame-
ters. The independent sample t test was used for variables 
with normal distribution and when the frequency distribu-
tion was not normal, the Mann-Whitney U test was used. 
Pair-wise analysis using Wilcoxon rank sum test for un-
matched samples was done to compare differences be-
tween patients with cavities and non-cavities, and con-
trols. The SPSS software package (Windows version 
7.5.2, SPSS Inc., Chicago, IL) was used for all statistical 
analyses. Results were considered statistically significant 
at p<0.05. 
 
Results 
Forty-one tuberculosis patients and 41 healthy control 
subjects (25 males and 16 females in both groups) were 
included in the study. Four patients had severe hemopty-
sis and were excluded from the study. Patients exhibited 
poorer nutritional status than controls (Table 1). 
Twenty-six patients (63%) had 3 positive sputum smears 
for acid fast bacilli, and 15 (37%) had 2 positive sputum 
smears, while 24 (59%) patients had a positive sputum 
culture. The main symptoms and signs exhibited by the 
patients were productive or unproductive cough (95%), 
hemoptysis (51%) and weight loss (83%). Five patients 
also demonstrated extra-pulmonary involvement as evi-
denced by lymph node enlargement (neck and axilla). 
Tuberculin testing of patients was positive (≥10 mm) in 
34 patients (83 %) and in 2 controls (5%). 
  As reported earlier28, haematocrit and the concentra-
tions of haemoglobin, albumin, plasma zinc and plasma 
retinol in active pulmonary tuberculosis patients were 
significantly lower, whereas zinc-protoporphyrin concen-
tration was higher than in healthy controls. A significant 
correlation between C-reactive protein and the concentra-
tion of micronutrients (plasma retinol, zinc and 
zinc-protoporphyrin) was not found28. 
 In patients, both circulating concentrations and un-
stimulated ex-vivo production of IL-6 and IL-1ra were  
 
Table 1. Characteristics of patients with active pulmonary tuberculosis and healthy controls * 
 Tuberculosis patients Controls  p ‡ 
No. of persons  41 41 - 
Female/male ratio 18/23 18/23 - 
Age (yrs) 28 ± 9 28 ± 9 - 
Body weight (kg) 46.1 ± 9.5 54.8 ± 9.3 <0.001 
Body mass index (kg/m2)  18.1 ± 3.1  21.9 ± 3.0 <0.001 
Body temperature (oC) 37.5 (37.0 - 38.2) 36.9 (36.0 - 37.0) <0.01 
Karnofsky score 87.5 ± 4.5 100 <0.001 
ESR (mm/h) 52 (25-82) 22 (12-31) <0.001 
C-reactive protein (mg/L) 35 (24-60) † 0 <0.001 
White blood cells (cells/mm3)  8626 ± 3207 6434 ± 1712 <0.001 
 
* Data are mean ±  SD or median (25th-75th percentiles). † C-reactive protein was not detectable in 14 patients and in none of the controls. ‡ 
Independent sample t test for normally distributed data; Mann-Whitney U test for data not-normally distributed. 
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significantly higher than in controls (p<0.001) (Fig 1), 
while LPS-stimulated cytokine production of IL-6 and 
IL-1ra were not significantly different from controls (data 
not shown). Circulating concentrations and ex-vivo pro-
duction of IL-1β and TNF-α were not significantly dif-
ferent between patients and controls (data not shown). As 
shown in Fig. 2, circulating concentrations of IL-6, as 
well as unstimulated production of IL-6 were higher in 
patients with pulmonary cavities (n=26), than in patients 
without cavities (n=15) (p<0.05) and control subjects 
(n=41) (p<0.001). A similar trend was seen for IL-6 in 
LPS stimulated blood samples (data not shown). Such 
differences were not found for IL-1β, TNF-α and IL-1ra 
(data not shown). 
 In healthy control subjects, there was no association 
between nutritional status and concentration of any of the 
cytokines. There was no significant association between 
IL-1β and nutritional status (data not shown). Concentra-
tions of circulating IL-6 were associated with low BMI, 
anaemia, and zinc deficiency, and marginal plasma retinol 
concentration was associated with ex-vivo LPS stimu-
lated IL-6 production in patients (Fig 3). Low BMI was 
also associated with higher concentrations of TNF-α in 
patients (Table 2). Patients with anaemia had significantly 
higher circulating IL-1ra concentrations than 
non-anaemic patients. Also, in patients with zinc defi-
ciency, LPS-stimulated production of TNF-α and IL-1ra 
was higher than in patients with normal plasma zinc con-
centrations (Table 2).  
 
Discussion  
In this carefully controlled study in Indonesia, we found 
elevated levels of IL-6 and IL-1ra in the circulation and in 
unstimulated whole blood cultures from tuberculosis pa-
tients. Increased cytokine production was associated with 
a low BMI and deficiencies of zinc, iron and retinol. In 
addition, the presence of pulmonary cavities was related 
to increased production of IL-6.   
 The problems of assessing micronutrient status during 
infection have made it difficult to determine whether
Figure 1. Distribution of circulating concentrations and unstimulated ex-vivo production of IL-6 and IL-1ra in patients with tuberculosis 
(n=41) and healthy controls (n=41). Each point represents one person. The median value for each group is indicated by a horizontal line. 
Significant differences were found between patients and controls (Mann-Whitney U test, ***: p<0.001). 
0
250
500
750
1000
Patients             Controls
C
irc
ul
at
in
g 
IL
-1
ra
(p
g/
m
L)
**
0
5000
10000
15000
Patients              Controls
IL
-1
ra
 u
ns
tim
ul
at
ed
(p
g/
m
L)
*** 
0
10
20
30
40
50
Patients           Controls
C
irc
ul
at
in
g 
IL
-6
 (p
g/
m
L)
0
25
50
75
Patients              Controls
IL
-6
 u
ns
tim
ul
at
ed
(p
g/
m
L)
** **
                                    Cytokines and nutritional status in TB                              222     
 
 
0
10
20
30
40
50
     Cavity    Non-cavity       Controls
C
irc
ul
at
in
g 
IL
-6
 (p
g/
m
L)
**
***
0
25
50
75
Cavity       Non-cavity     Controls
IL
-6
 u
ns
tim
ul
at
ed
(p
g/
m
L)
*
***
***
Figure 2. Distribution of circulating concentrations and unstimulated ex-vivo production of IL-6 in patients with cavitary (n=15) and 
non-cavitary (n=26), and control subjects (n=41). Each point represents one person. The median value for each group is indicated by a hori-
zontal line. Significant differences were found between groups (Wilcoxon rank sum test, *: p<0.05; ***: p<0.001). f: female; m: male. 
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Figure 3. Distribution of circulating concentrations of IL-6 in patients with tuberculosis in relation to the nutritional parameters: (A) body 
mass index (BMI); (B) haemoglobin (Hb); (C) plasma zinc, and of concentrations of IL-6 after 24 h incubation with LPS in relation to the 
plasma retinol concentration (D). Each point represents one person. The median value for each group is indicated by a horizontal line. Sig-
nificant differences were found between groups (Mann-Whitney U test, *: p<0.05). f: female; m: male. 
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Table 2. Circulating concentrations and concentrations after 24 h incubation without LPS (unstimulated) and with LPS (LPS) of IL-6, TNF-α and IL-1ra related to nutritional status in 
pulmonary tuberculosis patients†  
 n IL-6 (pg/mL) 
§ 
Circulating    Unstimulated       LPS‡ 
TNF-α (pg/mL) ¶ 
 Circulating    Unstimulated      LPS‡ 
IL-1ra (pg/mL) § 
 Circulating     Unstimulated          LPS‡ 
BMI: 
<18.5 kg/m2  
 
27
 
 
13 * 
(8-20) 
 
13 * 
(7-25) 
 
6,960 
 (3,870-10,950) 
 
124±20 * 
 
 
328±150 * 
 
  4,310±2,990 
 
 
340 
(270-455) 
 
2,150 
(1,500-3,000) 
 
12,000 
 (6,400-15,500) 
≥18.5 kg/m2 
 14 
4 
(4-10) 
5 
(4-15) 
5,175 
 (3,060-9,590) 109±14 242±87   4,600±2,790 
267 
(221-346) 
1,370 
(1,250-2,050) 
11,250 
 (3,900-13,250) 
Haemoglobin: 
<120f/<130m g/L 
 
24 
 
13 ** 
(7-22) 
 
14 
(8-30) 
 
6,230 
 (3,110-11,650) 
 
120±20 
 
 298±150 
 
  4,630±2,875 
 
357 * 
(266-500) 
 
2,100 
(1,500-3,070) 
 
12,000 
 (5,500-17,000) 
>120f/>130m g/L 17 4 (4-12) 
6 
(4-17) 
6,150 
 (3,850-10,025) 117±17  280±115   4,130±2,995 
280 
(225-340) 
1,500 
(1,250-2,100) 
10,500 
(4,075-13,250) 
Plasma retinol: 
<0.70 μmol/L  
 
10 
 
14 
(8-33) 
 
13 
(5-34) 
 
   10,540 * 
 (7,810-13,110) 
 
117±24 
 
 
 284±140 
 
 
  4,500±3,140 
 
 
400 
(258-538) 
 
   2,050 
(1,185-3,000) 
 
9,575 
(5,625-16,625) 
>0.70 μmol/L  20 8 (4-15) 
11 
(5-24) 
4,525 
 (2,485-8,000) 123±17  290±127   4,135±2,880 
317 
(251-443) 
2,000 
(1,460-3,140) 
12,250 
(3,940-15,125) 
Plasma zinc: 
<10.7 μmol/L 
 
8 
 
  15 * 
(12-30) 
 
  14 
(11-34) 
 
9,450 
 (5,040-14,250) 
 
  123±22 
 
 
 294±131 
 
 
  6,595±2,215 * 
 
285 
(250-412) 
 
1,650 
(1,225-1,950) 
 
16,500 * 
(12,250-19,500) 
>10.7 μmol/L  30 7 (4-15) 
  10 
  (4-23) 
5,650 
 (2,670-10,110) 117±19  289±139   3,915±2.930 
310 
(225-451) 
2,050 
(1,290-2,820) 
10,250 
(3,710-13,125) 
 
† Data are mean ± SD or median (25th-75th percentiles). 
Significant differences between groups: *: p<0.05; **: p<0.01 (§: Mann-Whitney U test, ¶: Independent sample t test); f: female; m: male. 
‡ LPS: lipopolysaccharide (LPS, E.Coli serotype 055:b5) 
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infections decrease micronutrient status itself in the long 
run. Many nutrients such as plasma retinol, zinc and iron 
are acute phase reactants, therefore, micronutrients show 
altered values during infections.29 This may therefore 
hamper the interpretation of the differences which were 
found between patients and controls.  
 With regard to the assessment of cytokine production in 
patients, all established methods have limitations. In this 
study, we used a whole blood culture system for ex-vivo 
production of cytokines. Although this method is well 
established and attractive for clinical studies, it does suf-
fer from variation.30  
 The elevation of IL-6 in tuberculosis patients is moder-
ate, especially when compared with the concentrations 
found in acute bacterial infections.31 Still, it could well be 
that the elevation of body temperature, the wasting and 
the elevation of C-reactive protein in tuberculosis are due 
to chronic elevation of this cytokine. An interesting find-
ing in our study is that concentrations of IL-6, were 
higher in patients with pulmonary cavities, signifying 
more severe disease, than in patients without cavities. 
This is in agreement with the observation that tuberculo-
sis patients who did not survive had higher circulating 
IL-6 levels than those who did.32 IL-6 is generally re-
garded as a cytokine that does not evoke tissue damage 
itself, in contrast to TNF-α for example. Production of 
IL-6 is, to a large extent, under the control of TNF-α and 
IL-1 and thus its concentration in blood may reflect local 
production of these cytokines in the lungs.  
 IL-1ra is a purely antiinflammatory cytokine, blocking 
IL-1 action at the receptor level, and excess of IL-1ra in 
the circulation is a common finding in disease.33 Because 
IL-1ra production is under the control of IL-6, among 
other cytokines, the increased concentrations of IL-6 may 
have been responsible for those of IL-1ra. We did not find 
significant differences between patients and controls in 
concentration of the proinflammatory cytokines IL-1β 
and TNF- α, but this is not remarkable, given the 
subacute nature of tuberculosis. However this finding 
does not preclude production of proinflammatory cyto-
kines at the site of disease in the lungs, as has been estab-
lished by others.34,35 
 The primary aim of this study was to investigate the 
association between cytokine production and nutritional 
status. It seems that increased production of both pro- and 
antiinflammatory cytokines may contribute to the defi-
ciencies of micronutrients in patients with tuberculosis.  
A low BMI was associated with higher concentrations of 
TNF-α and IL-6, which could fit in with the notion that 
both IL-6 and TNF-α induce anorexia and have catabolic 
properties at the level of muscle and fat tissue.36  
 Micronutrient deficiencies were also associated with 
cytokine production. Tuberculosis patients with marginal 
plasma retinol concentrations exhibited higher production 
of IL-6. This would suggest that IL-6 production has an 
inhibitory effect on the hepatic synthesis of reti-
nol-binding protein, thus suppressing the levels of plasma 
retinol-binding protein and plasma retinol. Alternatively, 
low concentrations of retinol and retinol-binding protein 
complex may be due to increased urinary excretion, as 
has been shown in shigellosis patients.37 Anaemia was 
associated with higher concentrations of IL-6 and IL-1ra.  
Anaemia of chronic disease seems to be a non-specific 
consequence of activation of the inflammatory cytokine 
network with simultaneous suppression of both erythro-
poietin production and the ability of erythroid progenitor 
cells to proliferate in response to the hormone.38 Patients 
with low zinc concentrations showed increased concen-
trations of IL-6, both in plasma and whole blood cultures, 
and increased concentrations of TNF-α and IL-1ra in 
LPS-stimulated whole blood cultures. Proinflammatory 
cytokines may induce the production of metallothionein, a 
zinc-binding protein. Although metallothionein spills over 
into the plasma, the largest bulk of it remains in the liver, 
and this may lead to redistribution of zinc to the liver with 
a transient depression of plasma zinc levels.39,40 Alterna-
tively, low plasma zinc concentration can also result from 
increased urinary zinc excretion as previously reported in 
patients with bladder cancer.41  
 So far, we have only been able to demonstrate associa-
tions between cytokines, nutrition and tuberculosis. 
Therefore, the biological significance of our findings re-
mains to be established. To further elucidate pathogenic 
relationships, an intervention study is needed to investi-
gate the effect of micronutrient supplementation on cyto-
kine production and its effect on the clinical response to 
treatment of active tuberculosis. 
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印尼未治療肺結核病人細胞激素與營養狀況有關 
 
雖然幾個研究已經探討過結核的細胞激素產生型態，但是結核病人的營養素缺
乏與細胞激素間的關係所知有限。本研究目的為評估在結核病期間，細胞激素
的濃度與營養狀況的相關。在印尼城市的醫院，41 名未治療的結核病人與其
配對的健康對照組，我們測量其身高與體重、鐵、維生素 A 及鋅；以及在循
環中和全血培養產生的細胞激素濃度。病人的血漿中介白質-6(IL-6)及介白質-1
接受體拮抗物(IL-1ra)顯著的較對照組高。有肺部空洞的病人(n=26)比起沒有空
洞的病人(n=15)有較高的 IL-6 濃度。身體質量指數小於 18.5kg/m2與較高濃度
的腫瘤壞死因子-α(TNF-α)及 IL-6有關。貧血者有較高的 IL-6及 IL-1ra。鋅缺
乏與高的 LPS-刺激產生 TNF-α及 IL-1ra有關。血漿視網醇濃度臨界缺乏與經
LPS 刺激後高濃度的 IL-6 相關。綜合以上，肺結核病人低微量營養素濃度與
細胞激素產生增加有關。介入性研究將可評估其因果關係。 
 
關鍵字：介白質-6、腫瘤壞死因子-α、介白質-1接受體拮抗物、身體質量指數、
微量營養素。 
 
